Last update: Jul 13, 2026

Ureters stay visible for hours with dye designed to vanish through kidneys

Urology news

Ureters stay visible for hours with dye designed to vanish through kidneys

A cross-disciplinary research team led by Hongjie Dai, director of the Materials Institute of Life Sciences and Energy (MILES) at the University of Hong Kong (HKU) in Shenzhen, has developed a promising near-infrared (NIR) ...

Jul 13, 2026

Second prostate-specific membrane antigen PET scan can change treatment for nearly half of prostate cancer patients

A second prostate-specific membrane antigen (PSMA) PET scan changed treatment plans for nearly half of patients whose first scan was negative, according to new research published in the July issue of The Journal of Nuclear ...

Jul 11, 2026

3511

Hidden pocket reveals new way to target prostate cancer's 'undruggable' ERG protein

In the United States, prostate cancer is a leading cause of cancer-related disease and death in men. About half of prostate cancer cases in patients of European ancestry have a gene rearrangement in which the genes TMPRSS2 ...

Jul 9, 2026

Researchers discover new form of hereditary prostate cancer

Researchers at the University of British Columbia have identified a new form of hereditary prostate cancer that, while rare, can cause aggressive disease at a young age. The discovery paves the way for genetic testing programs ...

Jul 9, 2026

New drug against metastatic prostate cancer made entirely from human proteins

A new cancer drug may be able to inhibit both tumor growth and the spread of aggressive prostate cancer. This is shown in a study conducted by researchers at Umeå University together with international collaborators, published ...

Jul 7, 2026

369

Should older men reassess their long-term prostate medications?

One in three men will experience moderate to severe lower urinary tract symptoms in their lifetime, with symptoms including frequent urination, difficulty starting urination, nocturia and a weak urine stream. Although these ...

Jul 7, 2026

Air pollution may alter how sperm genes function, major fertility study finds

New research presented at the 42nd Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE) suggests that exposure to air pollution may affect genes associated with sperm development, raising new ...

Jul 6, 2026

Pembrolizumab-belzutifan tied to improved disease-free survival in renal cell carcinoma

For patients with clear-cell renal cell carcinoma, pembrolizumab-belzutifan yields significantly higher disease-free survival, according to a study published in the July 2 issue of the New England Journal of Medicine.

Jul 6, 2026

Preserved testicular tissue produces early germ cells after childhood cancer treatment

Researchers at Karolinska Institutet have demonstrated that it is possible to create early germ cells from preserved testicular tissue of young boys facing cancer therapy. The study, published in the journal Human Reproduction ...

Jul 2, 2026

Should lowest-risk prostate 'cancer' still be called cancer? How changing the name could save lives

A growing number of prostate cancer experts argue that calling the lowest-risk prostate cancer "cancer" does more harm than good. A new UCLA-led study found removing the cancer label could dramatically reduce overtreatment ...

Jul 1, 2026

DNA methylation patterns may explain why some prostate cancers turn lethal

The prostate is the single organ most frequently afflicted by cancer in men. Prostate cancer affects approximately 4 million American men, with another 330,000 men expected to be diagnosed with the condition this year alone.

Jul 1, 2026

Next-generation HIF-2α inhibitor shows promise in kidney cancer translational clinical trial

The first-in-patient, single-arm ARC-20 clinical trial, led by Dana-Farber Cancer Institute's Toni K. Choueiri, MD, has evaluated casdatifan, a next-generation HIF-2α inhibitor, as monotherapy for metastatic clear cell renal ...

Jul 1, 2026

Early benign prostatic hyperplasia outcomes comparable for p-ThuLEP and open prostatectomy

For patients with benign prostatic hyperplasia (BPH), early functional outcomes are comparable with high-peak-power pulsed Thulium:YAG laser enucleation (p-ThuLEP) and open simple prostatectomy (OSP), but shorter hospitalization ...

Jun 30, 2026

Low grip strength should not be used as an independent predictor of prostate cancer in older men

New research suggests that low handgrip strength alone is not a reliable predictor of increased prostate cancer risk among older men. The relationship between low handgrip strength (HGS) and prostate cancer has long remained ...

Jun 29, 2026

Intravesical CAR T therapy opens door to bladder-sparing cancer treatment

Researchers at Weill Cornell Medicine, Cedars-Sinai Medical Center and Roswell Park Comprehensive Cancer Center have developed genetically engineered CAR T cells that specifically target and kill bladder cancer cells. The ...

Jun 26, 2026

What happens when celebrities talk about their prostate cancer?

When high-profile figures publicly discuss their prostate cancer, the public health impact can be immediate. The media coverage raises awareness. More men may seek information or medical advice.

Jun 26, 2026

Developing a new methodology to identify biomarkers for male infertility

Researchers from the EHU-University of the Basque Country have developed a robust protocol to detect the molecules involved in the metabolic reactions of sperm. The new method enables a detailed analysis even with small samples ...

Jun 25, 2026

Significant association identified between hepatitis C, overactive bladder

There is a significant association between hepatitis C virus (HCV) and overactive bladder (OAB), according to a study published online May 29 in BMC Urology.

Jun 25, 2026

Targeting cannabinoid receptors in bladder sensory pathways may alleviate pain of cystitis

The burning pain associated with cystitis affects millions of people around the world, and it can take days or even years for some patients to find relief from bladder pain, infection-related symptoms and the constant need ...

Jun 25, 2026

Six-month results confirm feasibility and early success of first in-human combined bladder-kidney transplant

The first-in-human fully vascularized bladder graft transplanted with a kidney has reached a promising six-month milestone, according to a new feasibility study published in The Lancet. The procedure, performed in May 2025, ...

Jun 24, 2026

New blood test detects more high-risk prostate cancer cases

A new blood test may make it easier to detect the most dangerous forms of prostate cancer early. In a study from Karolinska Institutet, the Stockholm3 blood test detected more clinically significant cancer cases than the ...

Jun 23, 2026

FDA approves oral Utebzi antibiotic for complicated urinary tract infections

The U.S. Food and Drug Administration has approved GSK's Utebzi (tebipenem pivoxil), an oral antibiotic, for the treatment of complicated urinary tract infections (cUTIs).

Jun 23, 2026

Testosterone therapy labels and limits may change under FDA proposal

The U.S. Food and Drug Administration (FDA) is asking drugmakers to update the prescribing information on testosterone replacement therapy products to reflect newer clinical evidence.

Jun 23, 2026

FDA approves Welireg with pembrolizumab for renal cell carcinoma

The U.S. Food and Drug Administration has approved Merck's Welireg (belzutifan) in combination with pembrolizumab or pembrolizumab and berahyaluronidase alfa-pmph (Keytruda Qlex) for the adjuvant treatment of renal cell carcinoma ...

Jun 19, 2026